Safety, Tolerability, and Immunogenicity of VAL-506440 in Healthy Adult Subjects
NCT03076385
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
201
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
VAL-506440
OTHER:
Placebo
Sponsor
ModernaTX, Inc.